Skip to main content

Table 1 Laboratory data at admission (Day 2)

From: Non-urate transporter 1, non-glucose transporter member 9-related renal hypouricemia and acute renal failure accompanied by hyperbilirubinemia after anaerobic exercise: a case report

Urinalysis

Biochemistry/Immunological test/Coagulation test

Protein (−)

±

TP (6.4~8.1 g/dL)

7.1 g/dL

HbA1c (4.6~6.2%)

5.2%

Occult blood (−)

–

Alb (3.9~4.9 g/dL)

4.0 g/dL

TSH (0.35~4.94 μIU/mL)

1.447 μIU/mL

Glucose (−)

–

UA (3.7~7.0 mg/dL)

2.7 mg/dL

FT4 (0.7~1.48 ng/dL)

0.83 ng/dL

Bilirubin (−)

–

BUN (7.2~20.0 mg/dL)

38.1 mg/dL

IgG (870~1700 mg/dL)

1433 mg/dL

Red blood cell (< 1/HPF)

< 1/HPF

Cr (0.5~1.1 mg/dL)

4.14 mg/dL

IgA (110~410 mg/dL)

163 mg/dL

Protein content (< 150 mg/gCr)

98 mg/gCr

eGFR (≧60 mL/min/1.73m2)

15 mL/min/1.73 m2

IgM (33~190 mg/dL)

129 mg/dL

PH (4.8–7.5)

5.5

TB (0.2~1.0 mg/dL)

2.5 mg/dL

C3 (86~160 mg/dL)

103 mg/dL

Myoglobin (≦10 ng/mL)

12.1 ng/mL

DB (0~0.4 mg/dL)

0.6 mg/dL

C4 (17~45 md/dL)

24.5 mg/dL

α1MG (≦8.0 mg/L)

11.91 mg/L

AST (10~40 IU/L)

23 IU/L

CH50 (30~45 U/mL)

49 U/mL

NAG (≦11.5 U/L)

3.8 U/L

ALT (5~45 IU/L)

21 IU/L

Antinuclear Ab (≦40)

1:40

β2MG (≦250 μg/L)

415 μg/L

ALP (104~338 IU/L)

149 IU/L

Anti-dsDNA-Ab (−)

(−)

FENA (< 1.0%)

0.61%

γ-GT (16~73 IU/L)

24 IU/L

Anti-Sm-Ab (−)

(−)

FEUA (5.5~11.1%)

50.5%

LDH (120~245 IU/L)

218 IU/L

Anti-MPO-ANCA (−)

(−)

Complete blood cell count

CK (50–230 IU/L)

300 IU/L

  

 White blood cell (3100~9500/μL)

9100/μL

Na (136~145 mEq/L)

138 mEq/L

Anti-PR3-ANCA (−)

(−)

 Neutrophil (43.7~76.4%)

76.0%

K (3.6~4.8 mEq/L)

4.5 mEq/L

Serum-Myoglobin (≦60.0 μg/mL)

67.1 ng/mL

 Lymphocyte (16.2~47.6%)

14.5%

Cl (99~109 mEq/L)

102 mEq/L

Lactate (4.0~16.0 mg/dL)

8.9 mg/dL

 Monocyte (2.9~7.9%)

8.5%

cCa (8.4~10.4 mg/dL)

9.2 mg/dL

PT (70~130%)

110%

 Eosinophil (0.6~9.0%)

0.8%

IP (2.2~4.6 mg/dL)

3.2 mg/dL

PT-INR (1.0 ± 0.15)

0.96

 Red blood cell (401~540 × 104/μL)

445 × 104/μL

Glu (70~109 mg/dL)

88 mg/dL

APTT (24.0~38.0 s)

25.1 s

 Hemoglobin (13.5–16.9 g/dL)

13.8 g/dL

TC (130~219 mg/dL)

193 mg/dL

Fibrinogen (170~360 mg/dL)

389 mg/dL

 Hematocrit (39.0~51.2%)

40.2%

TG (30~149 mg/dL)

69 mg/dL

FDP (< 10.0 μg/mL)

2.1 μg/mL

 Platelet (15.1~34.9 × 104/μL)

21.1 × 104/μL

CRP (≦0.3 mg/dL)

1.6 mg/dL

D-dimer (< 1.0 μg/mL)

0.6 μg/mL

  1. The reference values for each variable are presented in parentheses to the right or under it
  2. α1MG α1-microglobulin, NAG N-Acetyl-β-D-glucosaminidase, β2MG β2-microglobulin, FENA Fractional excretion of sodium, FEUA Fractional excretion of uric acid, TP Total protein, Alb Albumin, UA Uric acid, BUN Blood urea nitrogen, Cr Creatinine, eGFR Estimated glomerular filtration rate, TB Total bilirubin, DB Direct bilirubin, AST Aspartic aminotransferase, ALT Alanine aminotransferase, ALP Alkaline phosphatase, γ-GT γ-glutamyl transferase, LDH Lactate dehydrogenase, CK Creatine kinase, Na Sodium, K Potassium, Cl Chlorine, cCa Corrected calcium, IP Inorganic phosphorus, Glu Glucose, TC Total cholesterol, TG Total glyceride, CRP C-reactive protein, HbA1c Hemoglobin A1c, TSH Thyroid stimulating hormone, FT4 Free thyroxine, IgG Immunoglobulin G, IgA Immunoglobulin A, IgM Immunoglobulin M, Ab Antibody, dsDNA Double- stranded DNA, Sm Smith, MPO-ANCA Myeloperoxidase-anti-neutrophil cytoplasmic antibody, PR3-ANCA Proteinase-3-anti-neutrophil cytoplasmic antibody, PT Prothrombin time, PT-INR Prothrombin time-international normalized ratio, APTT Activated partial thromboplastin time, FDP Fibrinogen degradation products